ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 59 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,123,811 | -28.2% | 164,060 | +8.6% | 0.00% | -100.0% |
| Q2 2023 | $1,566,233 | +9.1% | 151,035 | -14.9% | 0.00% | 0.0% |
| Q1 2023 | $1,435,660 | +583.6% | 177,461 | +1354.6% | 0.00% | – |
| Q1 2022 | $210,000 | -69.8% | 12,200 | -74.5% | 0.00% | – |
| Q4 2021 | $695,000 | -28.9% | 47,828 | -12.0% | 0.00% | – |
| Q3 2021 | $978,000 | +29.4% | 54,320 | +26.3% | 0.00% | – |
| Q2 2021 | $756,000 | -28.2% | 43,000 | +2.9% | 0.00% | – |
| Q1 2021 | $1,053,000 | +1184.1% | 41,802 | +229.1% | 0.00% | – |
| Q4 2020 | $82,000 | +7.9% | 12,701 | -56.9% | 0.00% | – |
| Q3 2020 | $76,000 | -76.8% | 29,472 | -85.4% | 0.00% | – |
| Q2 2020 | $328,000 | +1950.0% | 202,183 | +1296.7% | 0.00% | – |
| Q3 2019 | $16,000 | -76.8% | 14,476 | -54.1% | 0.00% | – |
| Q2 2019 | $69,000 | – | 31,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |